Glenmark Achieves Positive Results for Anti-Diarrhea Molecule

Drug firm Glenmark Pharmaceuticals Monday said it has achieved positive results in human trials for its new drug molecule Crofelemer, which is aimed at treating diarrhea in adults.
Economic Times